Beneficência Portuguesa De São Paulo
🇧🇷Brazil
Clinical Trials
11
Active:2
Completed:2
Trial Phases
3 Phases
Phase 3:1
Phase 4:2
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (62.5%)Phase 4
2 (25.0%)Phase 3
1 (12.5%)Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study
Phase 4
Completed
- Conditions
- Arrhythmias, CardiacDiabetes Mellitus
- Interventions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Beneficência Portuguesa de São Paulo
- Target Recruit Count
- 174
- Registration Number
- NCT06721442
- Locations
- 🇧🇷
Hospital Beneficencia Portuguesa de São Paulo, São Paulo, SP, Brazil
🇧🇷Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil
Effectiveness of the Brazilian Diabetes Prevention Program
Not Applicable
Recruiting
- Conditions
- Prediabetic StatePre Diabetes
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Beneficência Portuguesa de São Paulo
- Target Recruit Count
- 1590
- Registration Number
- NCT06426277
- Locations
- 🇧🇷
Hospital de Clínicas de Goiás - UFG, Goiânia, Goiás, Brazil
🇧🇷Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil
Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices (ICP Monitor e EVD)
Not Applicable
Not yet recruiting
- Conditions
- Central Nervous System Infections
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Beneficência Portuguesa de São Paulo
- Target Recruit Count
- 1300
- Registration Number
- NCT06412549
Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil
Active, not recruiting
- Conditions
- Central Nervous System Infections
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Beneficência Portuguesa de São Paulo
- Target Recruit Count
- 554
- Registration Number
- NCT06412523
- Locations
- 🇧🇷
Hospital Geral Cleriston Andrade, Feira De Santana, BA, Brazil
🇧🇷Hospital da Cidade, Salvador, BA, Brazil
🇧🇷Unimed Vitória, Vitória, ES, Brazil
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens
Phase 4
Recruiting
- Conditions
- Febrile Neutropenia
- Interventions
- Drug: Ceftolozane-Tazobactam
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Beneficência Portuguesa de São Paulo
- Target Recruit Count
- 176
- Registration Number
- NCT06342115
- Locations
- 🇧🇷
A Beneficência Portuguesa de São Paulo, São Paulo, Brazil
- Prev
- 1
- 2
- 3
- Next
News
No news found